Aetna And Fresenius Medical Care North America Partner to Treat ESRD Patients
Aetna and FMC-NA are extending their value-based arrangement to better treat patients with ESRD—who are now eligible to enroll in Medicare Advantage (MA) plans. The partners will align reimbursement with quality benchmarks and develop metrics tied to CMS measures to better manage ESRD care.
Read the full article » | Posted 05-14-2021
Related Articles
- Baxter ASN Presence, 2018 Posted 10-05-2026
- Fresenius Kidney Care Reports PD Breakthroughs Posted 10-05-2026
- NIH to Consolidate Websites Under Nine Hubs Posted 09-18-2026
- FDA Warns Fresenius About Leaking PD Solution Bags and Particulates Posted 09-18-2026

